PubMed:32149769 / 1114-1209 JSON TXT

Annnotations TAB JSON ListView MergeView

Id	Subject	Object	Predicate	Lexical cue
T41	8-13	NCBITaxon:10239	denotes	viral
T42	33-38	NCBITaxon:10239	denotes	viral
T43	63-68	CHEBI:23888	denotes	drugs
T44	63-68	CHEBI:23888	denotes	drugs

Id	Subject	Object	Predicate	Lexical cue
EnjuParser_T164	0-3	DT	denotes	The
EnjuParser_T165	4-13	JJ	denotes	antiviral
EnjuParser_T166	14-24	NNS	denotes	activities
EnjuParser_T167	25-28	CC	denotes	and
EnjuParser_T168	29-38	JJ	denotes	antiviral
EnjuParser_T169	39-49	NNS	denotes	mechanisms
EnjuParser_T170	50-52	IN	denotes	of
EnjuParser_T171	53-62	JJ	denotes	potential
EnjuParser_T172	63-68	NNS	denotes	drugs
EnjuParser_T173	69-73	VBD	denotes	were
EnjuParser_T174	74-81	RB	denotes	further
EnjuParser_T175	82-94	VBN	denotes	investigated
EnjuParser_R161	EnjuParser_T167	EnjuParser_T164	arg1Of	and,The
EnjuParser_R162	EnjuParser_T166	EnjuParser_T165	arg1Of	activities,antiviral
EnjuParser_R163	EnjuParser_T166	EnjuParser_T167	arg1Of	activities,and
EnjuParser_R164	EnjuParser_T169	EnjuParser_T167	arg2Of	mechanisms,and
EnjuParser_R165	EnjuParser_T169	EnjuParser_T168	arg1Of	mechanisms,antiviral
EnjuParser_R166	EnjuParser_T167	EnjuParser_T170	arg1Of	and,of
EnjuParser_R167	EnjuParser_T172	EnjuParser_T170	arg2Of	drugs,of
EnjuParser_R168	EnjuParser_T172	EnjuParser_T171	arg1Of	drugs,potential
EnjuParser_R169	EnjuParser_T167	EnjuParser_T173	arg1Of	and,were
EnjuParser_R170	EnjuParser_T175	EnjuParser_T173	arg2Of	investigated,were
EnjuParser_R171	EnjuParser_T175	EnjuParser_T174	arg1Of	investigated,further
EnjuParser_R172	EnjuParser_T167	EnjuParser_T175	arg2Of	and,investigated

Id	Subject	Object	Predicate	Lexical cue
T9	0-95	DRI_Background	denotes	The antiviral activities and antiviral mechanisms of potential drugs were further investigated.

Id	Subject	Object	Predicate	Lexical cue
TextSentencer_T11	0-95	Sentence	denotes	The antiviral activities and antiviral mechanisms of potential drugs were further investigated.

Id	Subject	Object	Predicate	Lexical cue
tok215	0-3	DT	denotes	The
tok216	4-13	JJ	denotes	antiviral
tok217	14-24	NNS	denotes	activities
tok218	25-28	CC	denotes	and
tok219	29-38	JJ	denotes	antiviral
tok220	39-49	NNS	denotes	mechanisms
tok221	50-52	IN	denotes	of
tok222	53-62	JJ	denotes	potential
tok223	63-68	NNS	denotes	drugs
tok224	69-73	VBD	denotes	were
tok225	74-81	RBR	denotes	further
tok226	82-94	VBN	denotes	investigated
tok227	94-95	.	denotes	.
event24	82-94	OCCURRENCE	denotes	investigated